Breast Cancer News and Research

Latest Breast Cancer News and Research

Eleventh Edition of the Report on Carcinogens

The Department of Health and Human Services released its Eleventh Edition of the Report on Carcinogens today, adding seventeen substances to the growing list of cancer-causing agents, bringing the total to 246.

31 Jan 2005

Relationship between weight gain and breast cancer survival

Women who are overweight prior to breast cancer diagnosis, or who are lean but gain weight following diagnosis, are more likely to have their disease return or die of the disease, a new study shows. This effect was found to be particularly pronounced among women who had never smoked. The study is published online in the Journal of Clinical Oncology (JCO).

31 Jan 2005

Study focuses on best treatment for older women with receptor negative early breast cancer

Older women with hormone receptor negative early breast cancer who may currently be missing out on effective post-operative anticancer drugs will be able to participate in a new clinical trial specifically aimed at this group of women.

27 Jan 2005

Launch date announced for Abraxane to treat metastatic breast cancer

American Pharmaceutical Partners announced today that February 8, 2005 is the launch date of Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound). Abraxane will be marketed by the national sales force of Abraxis Oncology, APP's proprietary sales and marketing division.

25 Jan 2005

Plant protein mimics hormone that mitigates diabetes and obesity

A common protein that protects plants from fungal infection mimics the activity of a hormone in mammals that is linked to weight loss and is believed to play a role in mitigating heart disease, obesity and diabetes, according to a team of researchers at Purdue University and several collaborating institutions.

25 Jan 2005

Call for Anastrozole (Arimidex) to be the new preferred breast cancer treatment option

An international group of breast cancer experts called for the aromatase inhibitor (AI), anastrozole ('Arimidex'), to be considered as the new 'preferred treatment option' for postmenopausal women with early breast cancer.

24 Jan 2005

Annual mammograms best for women who have been treated for early stage breast cancer

Annual mammograms and doctor visits are the best follow-up strategy for women who have been treated for early stage breast cancer, according to a new review of recent research.

24 Jan 2005

Low to moderate amounts of alcohol reduce cardiovascular risk, while larger quantities raise it

Women see a slightly higher health benefit over men from alcohol consumption according to twelve separate studies reviewed in the Journal of Thrombosis and Haemostasis. However, more studies are needed to determine if there are more significant results from either wine, other spirits or beer.

19 Jan 2005

Adding radiation therapy to chemotherapy improves survival in patients with high-risk breast cancer

For patients with high-risk breast cancer treated with radical mastectomy and adjuvant chemotherapy, the addition of radiation therapy leads to better survival outcomes with few long-term toxic effects, according to a 20-year follow-up of a randomized trial, which appears in the January 19 issue of the Journal of the National Cancer Institute.

19 Jan 2005

The European mammography systems market

With breast cancer being identified as one of the leading causes of death among European women, several governments have begun to launch extensive screening and awareness programmes across the region. However, some countries have still not implemented the planned programmes due to budgetary or socio-economic constraints.

19 Jan 2005

Avastin available across Europe within the next few weeks

Roche has announced that the European Commission has approved Avastin (bevacizumab, rhuMAb-VEGF), the new innovative anti-angiogenesis drug, for the treatment of patients with previously untreated metastatic colorectal cancer.

16 Jan 2005

Researchers shed new light on the development of cancers, particularly breast and prostate cancer

Researchers at Brown Medical School and Rhode Island Hospital have shed new light on the activation of a protein key to the development of cancers, particularly breast and prostate cancer, the most commonly diagnosed cancers in the United States.

13 Jan 2005

No link between eating fruits and vegetables and a subsequent decreased risk for breast cancer

Contrary to findings in previous studies, new research that includes a large group of women found no link between eating fruits and vegetables and a subsequent decreased risk for breast cancer, according to a study in this week’s JAMA.

12 Jan 2005

Novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some breast cancers

Based on successful animal studies, a novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some human breast cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.

10 Jan 2005

Potential new therapies for cancer and bleeding disorders

Lexicon Genetics announced today that it has advanced two of its drug discovery programs into preclinical development in preparation for investigational new drug (IND) applications.

10 Jan 2005

Why the Mediterranean diet appers to protect against breast cancer

U.S. researchers have uncovered reasons why the Mediterranean diet, with its high intake of oleic acid-rich olive oil, seems to protect against breast cancer. They have also found evidence that oleic acid may have a future role in treatment. The findings are reported (Monday 10 January) in Annals of Oncology.

9 Jan 2005

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.

9 Jan 2005

FDA approves Abraxane for metastatic breast cancer

American Pharmaceutical Partners, Inc. and American Bioscience, Inc. (ABI) announced that the U.S. Food and Drug Administration (FDA) has approved Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in metastatic breast cancer.

9 Jan 2005

Direct modulation of progesterone signaling appears to influence ovarian cancer risk

A woman's risk of ovarian cancer rises significantly if she carries either of two previously unexamined variations in the gene that codes for the progesterone receptor, according to a team of researchers led by scientists from the Keck School of Medicine of the University of Southern California.

5 Jan 2005

Study shows women with invasive lobular carcinoma may not need chemotherapy before surgery

Women with a rare type of advanced breast cancer who do not benefit from primary (pre-surgical) chemotherapy still have been found to do better in the long run than patients with a more common advanced breast cancer who do respond to chemotherapy.

3 Jan 2005

Breast Cancer News and Research

Latest Breast Cancer News and Research

Eleventh Edition of the Report on Carcinogens

Relationship between weight gain and breast cancer survival

Study focuses on best treatment for older women with receptor negative early breast cancer

Launch date announced for Abraxane to treat metastatic breast cancer

Plant protein mimics hormone that mitigates diabetes and obesity

Call for Anastrozole (Arimidex) to be the new preferred breast cancer treatment option

Annual mammograms best for women who have been treated for early stage breast cancer

Low to moderate amounts of alcohol reduce cardiovascular risk, while larger quantities raise it

Adding radiation therapy to chemotherapy improves survival in patients with high-risk breast cancer

The European mammography systems market

Avastin available across Europe within the next few weeks

Researchers shed new light on the development of cancers, particularly breast and prostate cancer

No link between eating fruits and vegetables and a subsequent decreased risk for breast cancer

Novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some breast cancers

Potential new therapies for cancer and bleeding disorders

Why the Mediterranean diet appers to protect against breast cancer

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

FDA approves Abraxane for metastatic breast cancer

Direct modulation of progesterone signaling appears to influence ovarian cancer risk

Study shows women with invasive lobular carcinoma may not need chemotherapy before surgery

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in